BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9769127)

  • 1. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
    Lüttges J; Vogel I; Menke M; Henne-Bruns D; Kremer B; Klöppel G
    Virchows Arch; 1998 Sep; 433(3):237-42. PubMed ID: 9769127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy.
    Henne-Bruns D; Vogel I; Lüttges J; Klöppel G; Kremer B
    World J Surg; 2000 May; 24(5):595-601; discussion 601-2. PubMed ID: 10787083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
    Conlon KC; Klimstra DS; Brennan MF
    Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
    Nitecki SS; Sarr MG; Colby TV; van Heerden JA
    Ann Surg; 1995 Jan; 221(1):59-66. PubMed ID: 7826162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of tumor extension of ductal adenocarcinoma of the pancreas based on histological findings].
    Hatori T; Takasaki K; Imaizumi T; Nakasako T; Harada N; Fukuda A
    Nihon Geka Gakkai Zasshi; 1997 Jul; 98(7):604-9. PubMed ID: 9276866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size.
    Ohta T; Nagakawa T; Ueno K; Kayahara M; Mori K; Kobayashi H; Takeda T; Miyazaki I
    Int Surg; 1993; 78(3):208-12. PubMed ID: 8276542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological determinants of survival in resected cases of pancreas cancer.
    Brower ST; Newman RM; Pertsemlidis D; Kreel I; Aufses AH
    HPB Surg; 1993 Aug; 7(1):1-12; discussion 13-4. PubMed ID: 8260431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in the operative treatment of ductal pancreatic carcinoma.
    Gebhardt C; Meyer W; Reichel M; Wünsch PH
    Langenbecks Arch Surg; 2000 Jan; 385(1):14-20. PubMed ID: 10664114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
    Benassai G; Mastrorilli M; Quarto G; Cappiello A; Giani U; Mosella G
    Chir Ital; 2000; 52(3):263-70. PubMed ID: 10932371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical possibilities for pancreatic cancer: extended resection.
    Kremer B; Vogel I; Lüttges J; Klöppel G; Henne-Bruns D
    Ann Oncol; 1999; 10 Suppl 4():252-6. PubMed ID: 10436834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A result of surgical treatment for ductal adenocarcinoma of the head of the pancreas].
    Moon HJ; Jang KT; Heo JS; Choi SH; Joh JW; Kim YI
    Korean J Gastroenterol; 2003 Aug; 42(2):156-63. PubMed ID: 14532721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated pancreatectomy for ductal carcinoma of the head of the pancreas.
    Mimura H; Mori M; Hamazaki K; Tsuge H
    Hepatogastroenterology; 1994 Oct; 41(5):483-8. PubMed ID: 7851858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
    Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
    Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.
    Zacharias T; Jaeck D; Oussoultzoglou E; Neuville A; Bachellier P
    J Gastrointest Surg; 2007 Mar; 11(3):350-6. PubMed ID: 17458610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of portal invasion by pancreatic head carcinoma.
    Nakao A; Harada A; Nonami T; Kaneko T; Inoue S; Takagi H
    Surgery; 1995 Jan; 117(1):50-5. PubMed ID: 7809836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.